At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation of a stent, often a drug-eluting stent, though most published data originated in the era of bare-metal stents. This article reviews the indications for and biology of coronary-artery stents, focusing on recent advances in drug-eluting stents.
Jiro Aoki, Andrew T.L. Ong, Gastón A. Rodríguez-Granillo, Eugène McFadden, Carlos A.G. van Mieghem, Marco Valgimigli, Keiichi Tsuchida, Georgios Sianos, Evelyn Regar, Peter P.T. de Jaegere, Willem J. van der Giessen, Pim J. de Feyter, Ron T. van Domburg, Patrick W. Serruys
David J. Cohen, Ben van Hout, Patrick W. Serruys, Friedrich W. Mohr, Carlos Macaya, Peter den Heijer, M.M. Vrakking, Kaijun Wang, Elizabeth M. Mahoney, Salma Audi, Katrin Leadley, Keith D. Dawkins, A. Pieter Kappetein
Marie-Claude Morice, Antonio Colombo, Bernhard Meier, Patrick W. Serruys, Corrado Tamburino, Giulio Guagliumi, Eduardo Sousa, Hans-Peter Stoll, for the REALITY Trial Investigators
Discussion(0)
No comments yet. Be the first to comment.